Cell-specific, activatable, and theranostic prodrug for dual-targeted cancer imaging and therapy.
about
Reactive-Oxygen-Species-Responsive Drug Delivery Systems: Promises and ChallengesA Synthetic Aptamer-Drug Adduct for Targeted Liver Cancer TherapyMultifunctional biocompatible chitosan-polypyrrole nanocomposites as novel agents for photoacoustic imaging-guided photothermal ablation of cancer.Assessing the barriers to image-guided drug delivery.Environment-responsive nanophores for therapy and treatment monitoring via molecular MRI quenching.Structural diversity in native cyclodextrins/folic acid complexes--from [2]-rotaxane to exclusion compound.Assembled microcapsules by doxorubicin and polysaccharide as high effective anticancer drug carriers.Gold-Coated Fe3O4 Nanoroses with Five Unique Functions for Cancer Cell Targeting, Imaging and Therapy.Carboxymethyl chitosan-folic acid-conjugated Fe3O4@SiO2 as a safe and targeting antitumor nanovehicle in vitro.Theranostic Au cubic nano-aggregates as potential photoacoustic contrast and photothermal therapeutic agentsModified AS1411 Aptamer Suppresses Hepatocellular Carcinoma by Up-Regulating Galectin-14.Self-carried curcumin nanoparticles for in vitro and in vivo cancer therapy with real-time monitoring of drug releaseBiotargeted nanomedicines for cancer: six tenets before you beginBiological evaluation of protein nanocapsules containing doxorubicinUtilizing G2/M retention effect to enhance tumor accumulation of active targeting nanoparticles.Self-assembled Multifunctional DNA Nanoflowers for the Circumvention of Multidrug Resistance in Targeted Anticancer Drug Delivery.Noncanonical self-assembly of multifunctional DNA nanoflowers for biomedical applications.Stimuli-responsive cancer therapy based on nanoparticles.Drug delivery and release systems for targeted tumor therapy.Small conjugate-based theranostic agents: an encouraging approach for cancer therapy.Nanomaterial-based activatable imaging probes: from design to biological applications.Smart linkers in polymer-drug conjugates for tumor-targeted delivery.Enhancing targeted tumor treatment by near IR light-activatable photodynamic-photothermal synergistic therapy.Selective in vivo metabolic cell-labeling-mediated cancer targeting.A Thioacetal Photocage Designed for Dual Release: Application in the Quantitation of Therapeutic Release by Synchronous Reporter Decaging.Rational design of multifunctional small-molecule prodrugs for simultaneous suppression of cancer cell growth and metastasis in vitro and in vivo.Photo-triggered fluorescent theranostic prodrugs as DNA alkylating agents for mechlorethamine release and spatiotemporal monitoring.A DT-diaphorase responsive theranostic prodrug for diagnosis, drug release monitoring and therapy.Biotin-guided anticancer drug delivery with acidity-triggered drug release.A smart tumor targeting peptide-drug conjugate, pHLIP-SS-DOX: synthesis and cellular uptake on MCF-7 and MCF-7/Adr cells.NIR Fluorogenic Dye as a Modular Platform for Prodrug Assembly: Real-Time in vivo Monitoring of Drug Release.Targeted theranostic prodrugs based on an aggregation-induced emission (AIE) luminogen for real-time dual-drug tracking.Conjugated-polyelectrolyte-based polyprodrug: targeted and image-guided photodynamic and chemotherapy with on-demand drug release upon irradiation with a single light source.A binuclear gold(I) complex with mixed bridging diphosphine and bis(N-heterocyclic carbene) ligands shows favorable thiol reactivity and inhibits tumor growth and angiogenesis in vivo.Tailored doxorubicin-hyaluronan conjugate as a potent anticancer glyco-drug: an alternative to prodrug approach.Biodegradable ZnO@polymer core-shell nanocarriers: pH-triggered release of doxorubicin in vitro.Fluorescent chemical probes for accurate tumor diagnosis and targeting therapy.Fluoride as an inducible DNA cross-linking agent for new antitumor prodrug.Folate-modified gold nanoclusters as near-infrared fluorescent probes for tumor imaging and therapy.Versatile fluorescence resonance energy transfer-based mesoporous silica nanoparticles for real-time monitoring of drug release.
P2860
Q28468319-9363C9CD-04DF-4324-B16C-6F26BCB89941Q28550592-8F22E860-1E72-4111-999D-874D540565CAQ30361758-1E420DDA-6481-4F21-95A5-721B29471346Q30422169-6F867B82-2FE1-469B-93A8-623A7EF245E1Q33939863-FF4F36CB-E841-4C64-A14E-D68953F85B86Q34290165-DA5DA50E-C842-4D8B-9898-D978D5B930F8Q34647612-DC9E55C3-45D5-46A4-A32B-983CBEF454C7Q34703015-99195D1A-9E23-44C0-A72B-A2C520B9384CQ35130869-102E50AB-E293-4561-BD7E-E3898A8505DDQ35132638-C847566F-56DE-4634-A4B8-84F50BB449C3Q36095778-7C3C6813-7DB9-497D-BD7B-7F8A6E148D6DQ36258999-ED70C9EB-3EA7-4875-B766-1A38857E240AQ36814280-589012D8-D653-4CE8-8328-422E2DC33F9CQ36870638-465A96B3-3969-4182-9C31-0CA28788BAEAQ36980441-F469C3A6-503D-4C4C-8ACD-F697A9707A44Q37351040-0ACA5F6C-CD43-4F8E-A5A5-8AD48B6B5CA1Q37374944-B550142A-D05D-498A-8D2D-EFEC69D6538AQ38233457-C707390C-3CD2-49BB-9A99-E8D7640634CAQ38363691-EBFAF329-1B73-47BC-9DAF-5758ADE241F6Q38539464-53C09524-AFDF-4459-9235-A7256FC5671EQ38555053-9C5890FA-CC77-433E-9B70-F3686D851EF5Q38631193-7AA2C292-8A88-4BDC-BADA-0927A140EF0DQ38705464-8D2DF250-ACA5-4EF4-A53D-93500F60176DQ38716684-F5506A4E-466E-4B32-B39F-FCA382441C36Q38728260-4E9170BE-7E12-4C1A-9152-7011FD99D955Q38782458-283C5094-20D6-47C7-B8AC-60D029906011Q38872474-3A2FED0E-AA4D-4CBA-819D-F92E34A5F66FQ38875321-99B6879D-1D1B-497C-B844-19FF4898403FQ38877017-0A98DD05-AA42-4280-8CA3-B71A359D5507Q38889775-28FECDFC-FEEB-4B88-BD0D-3952A48C6BBFQ38890277-6D27313C-421C-426D-BC46-84C932E812E9Q38964655-EC844552-CC3B-4B9A-BA70-8CAFF0014DBBQ38991558-7CAC08C3-5D92-4CFF-B0F8-FDDB9A7C9D48Q39004496-E981A630-ACC0-405D-B4B9-B6C68796BE24Q39077970-C94CFFB6-AFDB-42EF-AC76-A7F70AF6C5A4Q39184856-8CB4DFF2-D058-46F7-B8CC-9028D98CBFCCQ39187880-DB83FD89-8816-42E0-BA96-C2306B29F2F1Q39190357-EFC5F599-95F8-41D4-B2F2-63C368EF8ACEQ39289120-C15DB726-879F-4656-A9D6-A6DDF23E2213Q39848926-1B3F38F3-BD13-4FD7-89AE-30B6FA71D4C5
P2860
Cell-specific, activatable, and theranostic prodrug for dual-targeted cancer imaging and therapy.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Cell-specific, activatable, an ...... ed cancer imaging and therapy.
@en
type
label
Cell-specific, activatable, an ...... ed cancer imaging and therapy.
@en
prefLabel
Cell-specific, activatable, an ...... ed cancer imaging and therapy.
@en
P2093
P2860
P356
P1476
Cell-specific, activatable, an ...... ed cancer imaging and therapy.
@en
P2093
Charalambos Kaittanis
J Manuel Perez
Oscar J Santiesteban
Santimukul Santra
P2860
P304
16680-16688
P356
10.1021/JA207463B
P407
P577
2011-09-27T00:00:00Z